NetRegulus Receives $7.2M in Series B Funding
"Given the current economic environment, we're especially excited by this vote of confidence in our ability to move to the forefront in a very competitive sector," said Mark Schaub, CEO of NetRegulus. "These funds will help us achieve our goal to be the undisputed leader in quality, clinical, and regulatory data management."
Keith Bank, Managing Director of KB Partners, concurs with Schaub's forecast. "NetRegulus is uniquely positioned to be the leader in this expanding field," he said. "They have a very unique and diverse product offering, along with a solid management team with unparalleled domain expertise." Gordon Pan, a Partner in Baird Venture Partners, said his group was also impressed by NetRegulus management. "The company has demonstrated the ability to execute in a tough economic climate," he said. "Management's ability to generate significant revenue growth and customer traction with blue chip accounts is quite impressive."
About NetRegulus
Oakbrook Terrace, Illinois-based NetRegulus is a privately held firm that has pioneered software solutions for clinical, quality, and regulatory data management for the life sciences industry since 1998. The company has gained an international reputation for best-in-class Web- and Windows-based software that meets or exceeds organizational goals and individual user requirements. Fully compliant with the FDA's 21 CFR Part 11 requirement, the firm offers business process-based solutions for complaint handling, corrective and preventive (CAPA) management, clinical study data management, adverse event tracking, nonconformance handling, and other quality, clinical, and regulatory needs. Visit www.netregulus.com for more information.
About KB Partners
KB Partners is a Chicago-based venture capital firm established in 1996 to make investments in early-stage technology companies in the Midwestern U.S. KB's objective is to help build dominant new enterprises by partnering with talented entrepreneurs and experienced managers.
KB Partners manages two venture funds totaling more than $95 million. The firm's investors include high net-worth individuals, investment companies, and institutions with which KB has established relationships. More information on KB Partners is available at www.kbpartners.com.
About Baird Venture Partners
Baird, founded in 1919, is an international asset management, investment banking, wealth management and private equity firm with offices in the United States, United Kingdom, France, Spain and Germany. Baird's principal operating subsidiaries are Robert W. Baird & Co. in the United States and Robert W. Baird Group Ltd. in Europe. Baird has been in the private equity business since the late 1980s and has raised and managed nearly $1 billion across three fund groups. Baird Venture Partners ("BVP") makes private equity investments in early stage companies with outstanding growth potential in three industry sectors: Business Services, Applied Technology and Life Sciences /Healthcare. In addition to BVP, Baird Capital Partners makes investments in late stage growth and change-of-control opportunities with U.S.-based middle market companies, and Granville Baird Capital Partners invests in high-growth companies across Europe. For more information, please visit Baird Venture Partners' website at www.bairdventurepartners.com.
About Odin Capital Group
Odin Capital Group, LLC, is a private equity investment firm based in Omaha, Nebraska. Partners David McLeese, Thompson Rogers and Donna Walsh founded the firm in 1999. Odin focuses on making $1 million to $5 million investments in early and middle stage private companies. Odin Capital Group is the general partner of the Odin Fund I, L.P., a $41 million private equity fund that had its initial closing in October 2000. More information on Odin Capital Group is available at www.odincapital.com.
NetRegulus, Inc.